Dr. Peter S. Kay, MD
Gastroenterology (Gastroenterology Physician)
- Medicare participating
At a glance
- Medical school
- University of Chicago, Pritzker School of Medicine (1991)
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 330
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1991Medical school: University of Chicago, Pritzker School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Gastroenterology Physician primary
OR license MD20376
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sacred Heart Medical Center - Riverbend Springfield, OR
- Mercy Medical Center Roseburg, OR
- Bay Area Hospital Coos Bay, OR
- Peace Harbor Medical Center Florence, OR
Medical groups
- Eugene Gastroenterology Consultants PC (16 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 330
- Services billed
- 877
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 375 | 196 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 125 | 125 |
| Biopsy of large bowel using a flexible endoscope | 87 | 87 |
| Established patient office or other outpatient visit, 20-29 minutes | 75 | 60 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | 56 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 42 | 42 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 30 | 30 |
| Established patient office or other outpatient visit, 30-39 minutes | 24 | 23 |
| New patient office or other outpatient visit, 45-59 minutes | 21 | 21 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 18 | 18 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Peg 3350-Electrolyte (sodium chloride/nahco3/kcl/peg) | 386 |
| Pantoprazole Sodium Other prescribers in Springfield, OR | 289 |
| Omeprazole Other prescribers in Springfield, OR | 121 |
| Sod Sulf-Potass Sulf-Mag Sulf (sodium, potassium,mag sulfates) Other prescribers in Springfield, OR | 93 |
| Mesalamine Other prescribers in Springfield, OR | 61 |
| Famotidine Other prescribers in Springfield, OR | 57 |
| Mesalamine Er (mesalamine) Other prescribers in Springfield, OR | 48 |
| Sutab (sod sulf/pot chloride/mag sulf) | 48 |
| Colestipol Hcl Other prescribers in Springfield, OR | 40 |
| Azathioprine Other prescribers in Springfield, OR | 39 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 7 payments worth $211 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $68.49 |
|---|---|
| AbbVie Inc. | $56.75 |
| Braintree Laboratories, Inc. | $41.32 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.54 |
| Janssen Biotech, Inc. | $21.62 |
| Food and Beverage | $142 |
|---|---|
| Education | $68.49 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Jul 29, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $68.49 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.